Avistone Biotechnology Co., Ltd.
Clinical trials sponsored by Avistone Biotechnology Co., Ltd., explained in plain language.
-
New pill for advanced cancers enters first human tests
Disease control OngoingThis early-phase study tests a new oral drug, ANS014004, in about 40 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug shrink…
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New targeted pill takes on tough lung cancer in major trial
Disease control ENROLLING_BY_INVITATIONThis study tests a new oral drug, PLB1004, against standard chemotherapy (with or without an immunotherapy) in about 327 people with advanced non-small-cell lung cancer that has a specific genetic change called EGFR exon 20 insertion. The goal is to see if PLB1004 can keep the ca…
Phase: PHASE3 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC